PTCT
#2717
PTC Therapeutics, Inc. - Common Stock
81.0 8 USD
-0.04%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-4.44%
Monthly Change
+8.53%
6 month change
+4.90%
Year Change
+66.56%
Previous Close
84.8 5
Open
81.5 7
Low
80.9 5
High
82.0 3
Volume
180
Financials
- Market Capitalization 672.55 M
- Employee 991
- Founded 1998
- CEO Matthew B. Klein
- Website www.ptcbio.com
- Headquarter Delaware, United States
- FIGI BBG000QT15P7
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
9.76
Price to sales ratio
3.88
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2689 |  MNPR Monopar Therapeutics Inc. - Common Stock | 100.83 USD | -5.41% | +2.41% | +69.72% | +84.60% | 675.47 M USD | ||
| 2715 |  BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 8.35 USD | +0.36% | -0.48% | +8.87% | -12.01% | 668.89 M USD | ||
| 2719 |  RLMD Relmada Therapeutics, Inc. - Common Stock | 6.44 USD | +0.47% | +2.55% | -1.68% | +955.74% | 675.49 M USD | ||
| 2720 |  RGNX REGENXBIO Inc. - Common Stock | 12.57 USD | -9.89% | -15.98% | +97.64% | -6.40% | 649.84 M USD |
Frequently asked questions about PTC Therapeutics, Inc. - Common Stock
What is the PTC Therapeutics, Inc. - Common Stock stock price today?
The current price of PTC Therapeutics, Inc. - Common Stock (PTCT) is 81.08. Over the past 24 hours, the stock has changed by -4.44%. Follow the PTCT chart for real-time price dynamics.
What is the stock ticker of PTC Therapeutics, Inc. - Common Stock?
PTC Therapeutics, Inc. - Common Stock trades under the ticker PTCT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is PTC Therapeutics, Inc. - Common Stock stock going up?
PTCT has changed by -6.17% over the last week, +8.53% over the last month, and +66.56% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was PTC Therapeutics, Inc. - Common Stock net income for the last quarter?
PTC Therapeutics, Inc. - Common Stock reported net income of -2.81 M for the last quarter. The previous quarter showed -134.97 M, which means net income changed by +97.92%.
How many employees does PTC Therapeutics, Inc. - Common Stock have?
As of the latest available data, PTC Therapeutics, Inc. - Common Stock has 991 employees. Workforce size can provide additional context about the company's scale and operations.
What is PTC Therapeutics, Inc. - Common Stock EBITDA?
PTC Therapeutics, Inc. - Common Stock EBITDA is 58.57 M, and its EBITDA margin is 21.49%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy PTC Therapeutics, Inc. - Common Stock stock?
You can buy PTC Therapeutics, Inc. - Common Stock (PTCT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in PTC Therapeutics, Inc. - Common Stock stock?
Investing in PTC Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PTCT chart and related analysis on metatrader.com as part of your research.